SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-015553
Filing Date
2014-01-21
Accepted
2014-01-21 11:32:36
Documents
14
Period of Report
2014-01-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d660702d8k.htm 8-K 15057
2 EX-99.1 d660702dex991.htm EX-99.1 27865
3 GRAPHIC g6607021.jpg GRAPHIC 122705
4 GRAPHIC g66070210.jpg GRAPHIC 150503
5 GRAPHIC g66070211.jpg GRAPHIC 182652
6 GRAPHIC g66070212.jpg GRAPHIC 157490
7 GRAPHIC g66070213.jpg GRAPHIC 184742
8 GRAPHIC g6607022.jpg GRAPHIC 375281
9 GRAPHIC g6607024.jpg GRAPHIC 203457
10 GRAPHIC g6607025.jpg GRAPHIC 148688
11 GRAPHIC g6607026.jpg GRAPHIC 248945
12 GRAPHIC g6607027.jpg GRAPHIC 352427
13 GRAPHIC g6607028.jpg GRAPHIC 116487
14 GRAPHIC g6607029.jpg GRAPHIC 178761
  Complete submission text file 0001193125-14-015553.txt   3382870
Mailing Address
Business Address 10165 MCKELLAR CT SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

IRS No.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-10961 | Film No.: 14537178
SIC: 2835 In Vitro & In Vivo Diagnostic Substances